Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Synapse. 2018 Aug 21;72(11):e22059. doi: 10.1002/syn.22059

Figure 7.

Figure 7.

Administration of purified subfractions of DUQ0002I bilaterally to the CA1 region of the hippocampus has no effects in males. (A) Mice treated with DUQ0002I-2 (n=11) show no difference in time immobile compared to vehicle (n=12) in the forced swim test. (B) Mice treated with DUQ0002I-3 (n=6) show no difference in time immobile compared to vehicle (n=5) in the forced swim test. (C) Mice treated with DUQ0002I-4 (n=6) show no difference in time immobile compared to vehicle (n=6) in the forced swim test. (D) Mice treated with DUQ0002I-1 (n=6) show no difference in time immobile compared to vehicle (n=6) in the tail suspension test. (E) Mice treated with DUQ0002I-1B (n=6) show no difference in time immobile compared to vehicle (n=5) in the tail suspension test. (F) Mice treated with DUQ0002I-1C (n=7) show no difference in time immobile compared to vehicle (n=7) in the forced swim test. Un-paired t-tests. Data shown as mean ± SEM.